Sibia, Meiji Seika Kaisha deal

The companies will co-develop and commercialize SIB-1508Y to treat Parkinson's disease.

Read the full 112 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE